19th Conference of the International Society of Geriatric Oncology

Integrative oncology – Leaving no one behind / GENEVA Switzerland 14-16 Nov 2019

  • November 14, 2019 Thursday
  • November 15, 2019 Friday
  • November 16, 2019 Saturday

November 14, 2019 / Thursday

10:00 - 13:00 IFA - SIOG Summit 2019 
Global Policy Dialogue on Cancer in the Ageing Population  
Venue: Palais des Nations, Building E, Door E-40, Room XXIV.
(Separate registration is required for this meeting.
Please click HERE to register IFA - SIOG Summit 2019)
19:00 - 21:00

SIOG 2019 Conference
Poster Welcome Reception
(to be held in CICG exhibition area)

With the support of    Logo etat de Geneve

November 15, 2019 / Friday

08:20 - 08:30

Opening Remarks
Hans Wildiers (BE), SIOG President

08:30 - 09:30

Overview of the Year
Chairs: Tanya Wildes (US), Sukeshi Arora (US)

News in oncology, Ravindran Kanesvaran (SG)
News in geriatrics, Marije Hamaker (NL)
Best of JGO, journal of geriatric oncology, Supriya Mohile (US), Siri Rostoft (NO)

09:30 - 10:30

Short Oral Abstract Presentations
Chairs: Heidi Klepin (US), Kah Poh (Melissa) Loh (MY & US)

O01 Outcomes that matter to patients? The Geriatric Oncology Surgical Assessment and Functional rEcovery after surgery (GOSAFE) study: subgroup analysis of 440 patients undergoing colorectal cancer surgery, Nicole Marie Saur (US)
O02 Crafting age friendly cancer care: A model for improvement utilizing the 4 Ms framework across the continuum of an NCI designated cancer center, Cassandra Vonnes (US)
O03 Assessment of the external validity of the NCCN guidelines for pancreatic ductal adenocarcinoma (PDAC) in a real population of elderly patients aged 70 years and older, Maria Grazia Rodriquenz (IT)
O04 Impact of the external validity of the national comprehensive cancer network and European Society for Medical Oncology guidelines for NSCLC on treatment outcomes in a population of patients aged 80 years and older, Nicolò Matteo Luca Battisti (GB)
O05 Factors affecting radiotherapy utilisation in geriatric oncology patients in New South Wales, Australia, Penny L Mackenzie (AU)
O06 Predictive power of Comprehensive Geriatric Assessment questionnaires to estimate the risk of early death in elderly cancer patients using Machine Learning, Gabrielle Ribeiro Sena (BR)
O07 Serious adverse events among older patients in the ALTTO trial, Lissandra Dal Lago (BE)
O08 Prostate cancer treatment and the risk of septicemia, Nikita Nikita (US)
O09 Combination of G8 screening tool and hand-grip strength to predict overall survival in patients with non-small cell lung cancer treated with stereotactic body radiotherapy, Kristian Kirkelund Bentsen (DK)
O10 Association between frailty and long-term homecare utilization in older adults following cancer surgery: a population-based retrospective cohort study, Tyler R Chesney (CA)
O11 Understanding factors influencing outcomes in older rural breast cancer patients, Kelly Kenzik (US)
O12 Obesity paradox in older cancer patients for middle and long-term mortality: a large prospective multicentre cohort study of 2071 patients, Claudia Martinez Tapia (FR)
O13 Association of LIPI score with immunotherapy outcomes in elderly population, Capucine Baldini (FR)
O14 The prevalence of luminal B subtype is higher in older postmenopausal women with ER+/HER2- breast cancer and is associated with inferior outcomes, Matthew N. Mills (US)
O15 Cytoplasmic cyclin E: an exquisite marker of tumour biology in older women with primary breast cancer, Ruth Mary Parks (GB)

10:30 - 11:00  Poster Viewing & Coffee Break
11:00 - 12:00

The Many Faces of Geriatric Assessment
Chairs: Holly Holmes (US), Christopher Steer (AU)

Acute oncology - Geriatric assessment in the emergency department, Thierry Chevalley (CH)
Polypharmacy or mobility assessment in patients with haematological malignancies, Tanya Wildes (US)
Geriatric assessment guided interventions - The role of occupational therapy and allied health, Mackenzi Pergolotti (US)

12:00 - 13:00

Breast Cancer MDT
Chairs: Enrique Soto Perez de Celis (MX), Kwok-Leung Cheung (GB)

Case Presentation 1: HER2+ early breast cancer 
Case Presentation 2: Triple negative early breast cancer
Panelists: Hans Wildiers (BE), Richard Simcock (GB), Ruth Parks (GB), Nicolò Matteo Luca Battisti (GB)

13:00 - 14:30  Break for Lunch
14:30 - 15:30

Colorectal Cancer MDT
Chair: Ponnandai Somasundar (US)

Case 1: Rectal cancer
Panelists: Siri Rostoft (NO), Nicole Saur (US), Athanasios Karampeazis (GR), Isacco Montroni (IT), Amy MacKenzie (US)

15:30 - 16:30 SIOG General Assembly
16:30 - 17:00  Poster Viewing & Young SIOG Poster Discussion & Coffee Break
17:00 - 18:30

Special Symposium: 
Research for Older Patients: All-Out Development from Humanities to Trials
by EORTC and INCa  
Chairs: Stuart Lichtman (US), Etienne Brain (FR)

Political commitment, Jérôme Foucaud (FR)
Barriers to participation, Florence Canoui Poitrine (FR)
Investigating elder patients’ experience of cancer: the role of social psychology of health, Myriam Pannard (FR)
Clinical trial eligibility and ASCO act, Stuart Lichtman (US)
Composite/co-primary endpoints and challenges in statistics at EORTC, Antonella Brunello (IT)
Epidemiological research and others CARG actions, Supriya Mohile (US), William Dale (US)
Pharmacology monitoring and DDI, Ginah Nightingale (US)
Asian perspective: the JCOG initiative, Tomonori Mizutani (JP)

18:30 - 19:30 Research on Geriatric Evaluation Symposium
(Joint Symposium with Young SIOG, Nursing/Allied Health, EUGMS)
Chairs: Martine Puts (CA) (NAH), Gábor Liposits (DK) (Young SIOG), Claire Falandry (FR) (EUGMS)

Impact of geriatric assessment on survival, function, and nutritional status in older patients with head and neck cancer: preliminary results of the EGeSOR randomized multicenter controlled trial, Florence Canoui Poitrine (FR)
Geriatric comanagement is associated with reduced 90day postoperative mortality among patients aged 75+ with cancer, Soo Jung Kim (US)
Prehabilitation in preoperative care, Barbara van Munster (NL)
20:00 - 22:30

Networking Dinner
(Further details can be found by clicking HERE)

November 16, 2019 / Saturday

07:00 - 08:30

Geriatric Evaluation Workshop
Separate registration is required for this workshop due to limited capacity.

Chairs: Cindy Kenis (BE) (NAH), Kah Poh (Melissa) Loh (US) (Young SIOG)

Case Introduction

Work on the Below Stations:
1) Geriatric screening tools (VES-13, Geriatric 8), Gábor Liposits (DK), Carolina Uranga (US)
2) Cognitive assessments (MOCA, MMSE, Mini-Cog), Allison Magnuson (US), Martine Puts (CA)
3) Physical Performance Batteries (SPPB, TUG, gait speed, etc.), Mackenzi Pergolotti (US), Schroder Sattar (CA)
4) Chemotherapy toxicity calculators (CARG, CRASH, MAX2), Nicolò Matteo Luca Battisti (GB), Sukeshi Arora (US)
5) Life expectancy calculators, Enrique Soto Perez de Celis (MX), Nina Rosa Neuendorff (DE)
6) Social support and psychological health, Kristen Haase (CA), Fábio Gomes (GB)
7) Medications and polypharmacy, Erika Ramsdale (US), Ginah Nightingale (US)

Wrap Up

08:30 - 09:30

Lung Cancer MDT
Chair: Ishwaria Subbiah (US)

Case 1: Stage IIIa lung cancer
Case 2a: Metastatic disease with good PS
Case 2b: Metastatic disease with poor PS
Panelists: Michael T. Jaklitsch (US), Holly Holmes (US), Lore Decoster (BE), Fábio Gomes (GB), Noam Vanderwalde (US)

09:30 - 10:30

Short Oral Abstract Presentations
Chairs: William Dale (US), Nina Rosa Neuendorff (DE)

Functional capacity and levels of physical activity as risk factors for hospitalization in elderly cancer patients: prospective cohort, Jurema T O L Sales (BR)
O17 Functional recovery in older women undergoing surgery for gynaecological malignancies: a systematic review and narrative synthesis, Fionna E Martin (GB)
O18 Fatigue is independently associated with functional status limitations in older adults with cancer – results from the cancer and aging resilience evaluation (CARE) registry, Grant R Williams (US)
O19 Decline in physical function (PF) is associated with pretreatment depressive symptoms, decreased mobility, more pain, and dyspnea in older cancer patients referred for systemic cancer treatment, Magnus Harneshaug (NO)
O20 Stepping on: Cancer edition changes behaviors and improves balance in older adults with cancer and their caregivers, Tanya M Wildes (US)
O21 Risk factors for falls in older persons with cancer: a multicenter study, Jessie De Cock (BE)
O22 The high impact of preoperative social frailty on overall survival in elderly gastrointestinal cancer patients, Rei Ono (JP)
O23 Implementation of a clinical frailty pathway at a cancer centre – a quality improvement project, Fábio Gomes (GB)
Geriatric and oncological predictors of survival and chemotherapy toxicities in elderly patients with metastatic non small cell lung cancer: an analysis of ESOGIA trial, Florence Canouï Poitrine (FR)
O25 Cancer-specific mortality and competing causes of death in older adults: a prospective multicenter cohort study (ELCAPA 19), Deborah Assouan (FR)
O26 Depressive symptom profiles and survival in older patients with cancer: latent class analysis of the ELCAPA cohort study, Florence Canouï Poitrine (FR)
O27 Discussing older patients during oncological multidisciplinary team meetings; is there a difference compared to younger patients? Suzanne Festen (NL)
O28 Patient-defined preferences and health outcome prioritization among older adults with cancer starting chemotherapy, Enrique Soto Perez De Celis (MX)
O29 “I have a doctor that handles all the other stuff.” Perceptions of older adults about discussing age-related conditions with their oncologists: A university of Rochester NCI community oncology research program (NCORP) geriatric assessment (GA) trial, Sindhuja Kadambi (US)
O30 Guided geriatric interventions (GI) in older adults with cancer: What, how, and for whom? The French PACA EST Cohort Experience, Rabia Boulahssass (FR)

10:30 - 11:00  Poster Viewing & Coffee Break
11:00 - 12:00

Hematology MDT
Chair: Vicki Morrison (US)

Case 1: AML
Case 2: Non Hodgkins Lymphoma
Panelists: Kah Poh (Melissa) Loh (MY & US), Heidi Klepin (US), Reinhard Stauder (AT), Konstantinos Christofyllakis (DE), Raul Cordoba (ES), Noam Vanderwalde (US)

12:00 - 13:00

Keynote Oral Abstract Presentations
Chairs: Siri Rostoft (NO), William P. Tew (US)

Patient Reported Outcomes Measures (PROMs) in geriatric patients undergoing major surgery for solid cancer. 90-day preliminary report on 643 patients from the Geriatric Oncology Surgical Assessment and Functional rEcovery after Surgery (GOSAFE) study, Isacco Montroni (IT)
KO2 Optimizing chemotherapy for frail and/ or elderly patients with advanced gastroesophageal cancer (aGOAC): The GO2 phase III trial, Daniel Edmund Bryan Swinson (GB)
KO3 Predicting life expectancy in older adults with advanced cancer: An evaluation of oncologists’ estimates and a geriatric assessment-based predictive model, Jennifer L Lund (US)
KO4 Prognostic value of inflammation-based routine biomarkers in older patients with cancer: pooled analysis of three prospective cohorts, Nadia Oubaya (FR)
KO5 Cost effectiveness of a geriatric oncology clinic, Zuhair Alam (CA)

13:00- 14:30  Break for Lunch
14:30 - 15:30

Prostate Cancer MDT
Chair: Cecilia Lund (DK)

Case 1: Localised prostate cancer
Case 2: Metastatic prostate cancer
Panelists: Lucinda Morris (AU), Antonella Brunello (IT), Cecilia Lund (DK), Patrice Jichlinski (CH)

15:30 - 16:30

Presidential Session
Chairs: Hans Wildiers, President (BE), Ravindran Kanesvaran, President-Elect (SG)

Presidential Address, Hans Wildiers (BE)
SIOG CEO Address, Najia Musolino (CH)
SIOG 2019 Paul Calabresi Award Presentation, Marije Hamaker (NL)
SIOG 2019 Awards:

SIOG 2019 Nursing & Allied Health Investigator Award
SIOG 2019 Young Investigator Award
SIOG 2019 Best Poster Award
SIOG 2020

16:30 - 17:00  Poster Viewing & Coffee Break
17:00 - 18:30

Debate Session: Controversial Issues in Geriatric Oncology
Chairs: Martine Extermann (US), Kwok-Leung Cheung(GB), Enrique Soto Perez de Celis (MX)

Debate 1:
Can chemotherapy toxicity calculators be used across diseases and settings?
Discussing arguments: 
FOR: Allison Magnuson (US)
AGAINST: Erin Moth (AU)

Debate 2: Should breast and colorectal cancer screening be carried out in older adults?
Discussing arguments:
FOR: Lodovico Balducci (US)
AGAINST: Shabbir Alibhai (CA)